HANGZHOU CONVERD CO., LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for HANGZHOU CONVERD CO., LTD..The latest application filed is for "method for producing virus and harvest liquid composition".

Company Profile

11.9.12

HANGZHOU CONVERD CO., LTD. - Hangzhou N/A CN
HANGZHOU CONVERD CO., LTD. - Hangzhou, Zhejiang CN
Hangzhou Converd Co., Ltd. - Zhejiang CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic agents and uses thereof for drugs for treatment of tumors and/or cancers Grant 11,446,345 - Hu , et al. September 20, 2	2022-09-20
Method For Producing Virus And Harvest Liquid Composition App 20220267713 - LIU; Yunfan ; et al.	2022-08-25
Application of oncolytic viruses as immunostimulants for treatment of tumors and/or cancers Grant 11,357,804 - Zhao , et al. June 14, 2	2022-06-14
Therapeutic Agents Comprising Nucleic Acids And Tcr Modified Immune Cells And Uses Thereof App 20210393686 - HU; Fang ; et al.	2021-12-23
Drug inclusion complex, preparation thereof, and preparation method thereof Grant 11,071,737 - Shi , et al. July 27, 2	2021-07-27
Oral preparation and preparation method thereof Grant 11,007,141 - Shi , et al. May 18, 2	2021-05-18
In vivo individualized systemic immunotherapeutic method and device Grant 10,980,859 - Hu , et al. April 20, 2	2021-04-20
Therapeutic compositions and applications that comprise nucleic acids and adoptively transferred immune cell App 20200289567 - Hou; Yafei ; et al.	2020-09-17
Isolated Recombinant Oncolytic Poxvirus, Pharmaceutical Composition, and Use Thereof in Treatment of Tumors and/or Cancer App 20200289591 - Fu; Jin ; et al.	2020-09-17
Isolated Recombinant Oncolytic Adenoviruses, Pharmaceutical Compositions, and Uses Thereof for Drugs for Treatment of Tumors and App 20200276252 - SHENG; Jipo ; et al.	2020-09-03
Application Of Oncolytic Viruses As Immunostimulants For Treatment Of Tumors And/or Cancers App 20200138882 - ZHAO; Ronghua ; et al.	2020-05-07
Method for Establishing Machine Learning Model for Predicting Toxicity of siRNA to Certain Type of Cells and Application Thereof App 20200020420 - Cai; Jinlu ; et al.	2020-01-16
Therapeutic Agents Comprising Oncolytic Vaccinia Viruses And Nk Cells, And Uses Thereof For Drugs For Treatment Of Tumors And/or App 20190343881 - HU; Fang ; et al.	2019-11-14
Therapeutic Agents And Uses Thereof For Drugs For Treatment Of Tumors And/or Cancers App 20190336549 - HU; Fang ; et al.	2019-11-07
Oral Preparation And Preparation Method Thereof App 20190000756 - SHI; Shuiping ; et al.	2019-01-03
Drug Inclusion Compound, Preparation Thereof, And Preparation Method Thereof App 20190000859 - SHI; Shuiping ; et al.	2019-01-03
In Vivo Individualized Systemic Immunotherapeutic Method and Device App 20160250292 - Hu; Fang ; et al.	2016-09-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.